跳至主要内容
临床试验/EUCTR2020-002864-30-NL
EUCTR2020-002864-30-NL进行中(未招募)1 期

Sulodexide for chronic heart failure: a proof of concept, randomized, placebo-controlled study

Amsterdam UMC, location AMC0 个研究点目标入组 64 人开始时间: 2020年6月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
64

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Chronic heart failure with reduced ejection fraction (HFrEF)
  • - Elevated NT-proBNP and signs of congestion (e.g. use of diuretics, peripheral edema)
  • - Stable diuretic and antihypertensive treatment
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 32
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 32

排除标准

  • - Estimated glomerular filtration rate (eGFR) <15 ml/min/1.73m2
  • - Hypotension (systolic < 105 mmHg or diastolic < 60 mmHg)
  • - Anticoagulant therapy or double antiplatelet therapy
  • - Recent cardiovascular event or hospital admission for heart failure

研究者

发起方
Amsterdam UMC, location AMC

相似试验